Company
United StatesPublic company, NYSE: AZNAstraZeneca LP (NYSE: AZN), Westborough, MA – FDA Inspections
Inspection records and compliance data for AstraZeneca LP in Westborough, Massachusetts. 5 FDA inspections on record, last inspected April 27, 2016. Publicly traded as NYSE: AZN.
Company Profile
This profile covers AstraZeneca LP based in Westborough, Massachusetts, United States.
FDA Inspection History
- FDA inspections
- 5
- OAI
- 0
- VAI
- 3
- NAI
- 2
- Form 483s
- 0
- Warning letters
- 0
First inspected May 17, 2010. Last inspected April 27, 2016.
Most cited issue areas
- Investigations of discrepancies, failures2 inspections
- Complete test data included in records1 inspection
- Contamination, chemical or physical change, deterioration1 inspection
FDA inspections (5)
| Date | Result | FDA center(s) | Insp. # |
|---|---|---|---|
| April 27, 2016 | VAI | Human Drugs · Drug Quality Assurance | 979534 |
| July 23, 2014 | NAI | Human Drugs · Drug Quality Assurance | 888632 |
| June 14, 2012 | NAI | Human Drugs · Drug Quality Assurance | 786512 |
| April 27, 2011 | VAI | Human Drugs · Drug Quality Assurance | 722306 |
| May 17, 2010 | VAI | Human Drugs · Drug Quality Assurance | 662811 |
FDA documents
No Form 483s, Warning Letters or EIRs on record.
Related Companies (10)
Companies with similar regulatory profiles, compliance history, and operations.
Company Information
Name
AstraZeneca LP
Stock ticker
AZN
Exchange
NYSE
Share price
$187.08
Market cap
$290.1B
Price as of
November 6, 2026
FEI Number
1220331
Address
50 Otis St, Westborough, Massachusetts 01581, United States
Country
United States
ID: aed77fd7-665b-4d39-96b1-13c588ef3a24